Maven Securities’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-55,000
| Closed | -$3.23M | – | 587 |
|
|
2023
Q4 | $3.23M | Sell |
55,000
-35,000
| -39% | -$2.06M | 0.07% | 53 |
|
|
2023
Q3 | $3.92M | Buy |
+90,000
| New | +$3.92M | 0.04% | 40 |
|
|
2022
Q1 | – | Sell |
-6,102
| Closed | -$895K | – | 673 |
|
|
2021
Q4 | $895K | Buy |
+6,102
| New | +$895K | 0.03% | 141 |
|
|
2021
Q1 | – | Sell |
-28,900
| Closed | -$6.35M | – | 1081 |
|
|
2020
Q4 | $6.35M | Buy |
+28,900
| New | +$6.35M | 0.63% | 35 |
|